Approval · Notice of Compliance 656 · 2003
ADRUCIL: Notice of Compliance 656
Issued September 16, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 656
- Date
- September 16, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADRUCIL | 02063921 | Cancelled Post Market |
Medicinal ingredients
- FLUOROURACIL 50 MG per ML